|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.4 BGN | 0.00% |
|
+0.58% | +2.35% |
Tchaikapharma High Quality Medicines AD reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was BGN 32.57 million compared to BGN 34.9 million a year ago. Revenue was BGN 33.15 million compared to BGN 34.92 million a year ago.
Net income was BGN 3.13 million compared to BGN 3.52 million a year ago. Basic earnings per share from continuing operations was BGN 0.0381 compared to BGN 0.0381 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.35% | 842M | |
| +20.91% | 43.54B | |
| +16.96% | 21.74B | |
| +9.05% | 13.53B | |
| +7.98% | 13.02B | |
| +33.80% | 11.28B | |
| -11.05% | 6.99B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.64% | 5.09B |
TCHAIKAPHARMA HIGH QUALITY MEDICINES AD 
